SYRE
Price
$16.97
Change
+$0.35 (+2.11%)
Updated
Jun 6 closing price
Capitalization
1B
53 days until earnings call
ZURA
Price
$1.26
Change
+$0.11 (+9.57%)
Updated
Jun 6 closing price
Capitalization
71.16M
Interact to see
Advertisement

SYRE vs ZURA

Header iconSYRE vs ZURA Comparison
Open Charts SYRE vs ZURABanner chart's image
Spyre Therapeutics
Price$16.97
Change+$0.35 (+2.11%)
Volume$309.21K
Capitalization1B
Zura Bio
Price$1.26
Change+$0.11 (+9.57%)
Volume$995.68K
Capitalization71.16M
SYRE vs ZURA Comparison Chart
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. ZURA commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a StrongBuy and ZURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (SYRE: $15.08 vs. ZURA: $1.00)
Brand notoriety: SYRE and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 105% vs. ZURA: 122%
Market capitalization -- SYRE: $1B vs. ZURA: $71.16M
SYRE [@Biotechnology] is valued at $1B. ZURA’s [@Biotechnology] market capitalization is $71.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 4 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • SYRE’s TA Score: 4 bullish, 3 bearish.
  • ZURA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than ZURA.

Price Growth

SYRE (@Biotechnology) experienced а +2.03% price change this week, while ZURA (@Biotechnology) price change was -3.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1B) has a higher market cap than ZURA($71.2M). ZURA has higher P/E ratio than SYRE: ZURA (7.96) vs SYRE (1.68). SYRE YTD gains are higher at: -35.223 vs. ZURA (-60.104). ZURA has higher annual earnings (EBITDA): -50.28M vs. SYRE (-208.57M). SYRE has more cash in the bank: 603M vs. ZURA (188M). SYRE (0) and ZURA (0) have equivalent revenues.
SYREZURASYRE / ZURA
Capitalization1B71.2M1,407%
EBITDA-208.57M-50.28M415%
Gain YTD-35.223-60.10459%
P/E Ratio1.687.9621%
Revenue00-
Total Cash603M188M321%
Total Debt0N/A-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYREZURA
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
57%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
59%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
72%
Advances
ODDS (%)
Bullish Trend 28 days ago
84%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+0.60%
BEAM - SYRE
56%
Loosely correlated
-0.88%
APGE - SYRE
53%
Loosely correlated
-1.30%
IMNM - SYRE
52%
Loosely correlated
+0.35%
CGON - SYRE
52%
Loosely correlated
-0.94%
XNCR - SYRE
52%
Loosely correlated
-2.58%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-0.26%
SYRE - ZURA
41%
Loosely correlated
+0.60%
KYMR - ZURA
40%
Loosely correlated
+2.35%
CCCC - ZURA
40%
Loosely correlated
-3.08%
BIESF - ZURA
40%
Loosely correlated
N/A
OCUL - ZURA
39%
Loosely correlated
+13.69%
More